A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
Clinical trial NCT06072586 · RECRUITING
Trial details
- NCT number
- NCT06072586
- Sponsor
- St. Joseph's Hospital and Medical Center, Phoenix
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2026-12-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.